Editorials

Statins for people at low risk

BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3908 (Published 21 July 2015) Cite this as: BMJ 2015;351:h3908

BMJ editor confirms that revenues from industry will be declared

I am pleased to report that BMJ's Executive Committee (on which I sit) has approved a proposal to publicly disclose revenues received from industry sources including the pharmaceutical and devices industries. This is in line with BMJ's commitment to greater transparency within medicine, research and publishing. The first declaration will be for revenues received in 2016 and will be published on bmj.com as soon as possible after the company accounts have been lodged with Companies House, probably July 2017. We will publish an editorial to alert readers to the declaration.

Competing interests: I am editor in chief of The BMJ and responsible for all that it contains. The BMJ is part of the publishing company BMJ, which is wholly owned by the BMA. I serve as a member of BMJ's Executive Committee and as a director on its Board.

09 March 2017
Fiona Godlee
Editor in chief
The BMJ, London WC1H 9JR